(5S)-2-[5-fluoro-1-[(3-fluoro-2-pyridinyl)methyl]pyrazolo[5,4-b]pyridin-3-yl]-5-methyl-5-(trifluoromethyl)-4-(3,3,3-trifluoropropylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-one;1-[(2-fluorophenyl)methyl]-3-(5-methyl-1H-1,2,4-triazol-3-yl)pyrazolo[5,4-b]pyridine;methyl N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]pyrazolo[5,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methylcarbamate
C59H48F10N22O3 — CID 161392400
Data last refreshed: (MolForge compound catalog, from PubChem)
About (5S)-2-[5-fluoro-1-[(3-fluoro-2-pyridinyl)methyl]pyrazolo[5,4-b]pyridin-3-yl]-5-methyl-5-(trifluoromethyl)-4-(3,3,3-trifluoropropylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-one;1-[(2-fluorophenyl)methyl]-3-(5-methyl-1H-1,2,4-triazol-3-yl)pyrazolo[5,4-b]pyridine;methyl N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]pyrazolo[5,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methylcarbamate
(5S)-2-[5-fluoro-1-[(3-fluoro-2-pyridinyl)methyl]pyrazolo[5,4-b]pyridin-3-yl]-5-methyl-5-(trifluoromethyl)-4-(3,3,3-trifluoropropylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-one;1-[(2-fluorophenyl)methyl]-3-(5-methyl-1H-1,2,4-triazol-3-yl)pyrazolo[5,4-b]pyridine;methyl N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]pyrazolo[5,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methylcarbamate (PubChem CID 161392400) has the molecular formula C59H48F10N22O3 and a molecular weight of 1303.16 g/mol. Its IUPAC name is (5S)-2-[5-fluoro-1-[(3-fluoro-2-pyridinyl)methyl]pyrazolo[5,4-b]pyridin-3-yl]-5-methyl-5-(trifluoromethyl)-4-(3,3,3-trifluoropropylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-one;1-[(2-fluorophenyl)methyl]-3-(5-methyl-1H-1,2,4-triazol-3-yl)pyrazolo[5,4-b]pyridine;methyl N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]pyrazolo[5,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methylcarbamate.
Molecular Properties
| Compound Name | (5S)-2-[5-fluoro-1-[(3-fluoro-2-pyridinyl)methyl]pyrazolo[5,4-b]pyridin-3-yl]-5-methyl-5-(trifluoromethyl)-4-(3,3,3-trifluoropropylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-one;1-[(2-fluorophenyl)methyl]-3-(5-methyl-1H-1,2,4-triazol-3-yl)pyrazolo[5,4-b]pyridine;methyl N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]pyrazolo[5,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methylcarbamate |
|---|---|
| PubChem CID | 161392400 |
| Molecular Formula | C59H48F10N22O3 |
| Molecular Weight | 1303.16 g/mol |
| Exact Mass | 1302.41 |
| IUPAC Name | (5S)-2-[5-fluoro-1-[(3-fluoro-2-pyridinyl)methyl]pyrazolo[5,4-b]pyridin-3-yl]-5-methyl-5-(trifluoromethyl)-4-(3,3,3-trifluoropropylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-one;1-[(2-fluorophenyl)methyl]-3-(5-methyl-1H-1,2,4-triazol-3-yl)pyrazolo[5,4-b]pyridine;methyl N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]pyrazolo[5,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methylcarbamate |
| SMILES | COC(=O)N(C)c1c(N)nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc1N.C[C@@]1(C(F)(F)F)C(=O)Nc2nc(-c3nn(Cc4ncccc4F)c4ncc(F)cc34)nc(NCCC(F)(F)F)c21.Cc1nc(-c2nn(Cc3ccccc3F)c3ncccc23)n[nH]1 |
| InChI | InChI=1S/C23H16F8N8O.C20H19FN8O2.C16H13FN6/c1-21(23(29,30)31)14-16(33-6-4-22(26,27)28)35-18(36-17(14)37-20(21)40)15-11-7-10(24)8-34-19(11)39(38-15)9-13-12(25)3-2-5-32-13;1-28(20(30)31-2)15-16(22)25-18(26-17(15)23)14-12-7-5-9-24-19(12)29(27-14)10-11-6-3-4-8-13(11)21;1-10-19-15(21-20-10)14-12-6-4-8-18-16(12)23(22-14)9-11-5-2-3-7-13(11)17/h2-3,5,7-8H,4,6,9H2,1H3,(H2,33,35,36,37,40);3-9H,10H2,1-2H3,(H4,22,23,25,26);2-8H,9H2,1H3,(H,19,20,21)/t21-;;/m0../s1 |
| InChIKey | VTDRKMVZAQKTOE-FGJQBABTSA-N |
| XLogP | 9.90 |
| TPSA | 320.86 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 22 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 94 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1303.16 |
| LogP ≤ 5 | 9.90 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 22 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161392400 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.